EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana

Francisco J Barrera-Téllez, Fernando D Prieto-Martínez iD, Alicia Hernández-Campos iD, Karina Martínez-Mayorga, Rafael Castillo-Bocanegra iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Francisco J Barrera-Téllez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico. Hauptthemen laut MEDLINE: Leishmania, Leishmaniasis, Antiprotozoal Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONACyT, FORDECYT-PRONACES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human leishmaniasis is a neglected tropical disease which affects nearly 1.5 million people every year, with Mexico being an important endemic region. One of the major defense mechanisms of these parasites is based in the polyamine metabolic pathway, as it provides the necessary compounds for its survival. Among the enzymes in this route, trypanothione reductase (TryR), an oxidoreductase enzyme, is crucial for the Leishmania genus’ survival against oxidative stress. Thus, it poses as an attractive drug target, yet due to the size and features of its catalytic pocket, modeling techniques such as molecular docking focusing on that region is not convenient. Herein, we present a computational study using several structure-based approaches to assess the druggability of TryR from L. mexicana, the predominant Leishmania species in Mexico, beyond its catalytic site. Using this consensus methodology, three relevant pockets were found, of which the one we call σ-site promises to be the most favorable one. These findings may help the design of new drugs of trypanothione-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeishmaniaLeishmaniasisAntiprotozoal AgentsHumansMolecular Docking SimulationNADH, NADPH Oxidoreductases

Stichwörter der Autor:innen

L. mexicanacosolvent molecular dynamicscryptic sitehotspotin silicometadynamicstrypanothione reductase

Substanzen

trypanothione reductaseNADH, NADPH OxidoreductasesAntiprotozoal Agents

Autor:innen und Institutionen

  • Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
  • Instituto de Química, Unidad Mérida, Universidad Nacional Autónoma de México, Carretera Mérida-Tetiz, Km. 4.5, Ucú 97357, Mexico.
  • Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Unidad Mérida, Universidad Nacional Autónoma de México, Sierra Papacal, Mérida 97302, Mexico.

ORCID-Profile: Fernando D Prieto-Martínez, Alicia Hernández-Campos, Rafael Castillo-Bocanegra

Förderung

  • CONACyT
  • FORDECYT-PRONACES

Zitieren

APA

Barrera-Téllez, F. J., Prieto-Martínez, F. D., Hernández-Campos, A., Martínez-Mayorga, K., & Castillo-Bocanegra, R. (2023). In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216046

Vancouver

Barrera-Téllez FJ, Prieto-Martínez FD, Hernández-Campos A, Martínez-Mayorga K, Castillo-Bocanegra R. In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216046

BibTeX
@article{BarreraTllez2023,
  author = {Barrera-Téllez, Francisco J and Prieto-Martínez, Fernando D and Hernández-Campos, Alicia and Martínez-Mayorga, Karina and Castillo-Bocanegra, Rafael},
  title = {In Silico Exploration of the Trypanothione Reductase (TryR) of L. mexicana},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216046}
}
Kostenlos starten →